The effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists on cardiovascular disease in patients with type 2 diabetes (Q91012614)
Jump to navigation
Jump to search
scientific article published on 06 February 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists on cardiovascular disease in patients with type 2 diabetes |
scientific article published on 06 February 2019 |
Statements
The effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists on cardiovascular disease in patients with type 2 diabetes (English)
2 references
Jacob Groenendyk
Nehal N Mehta
Evgenia Gourgari
6 February 2019
1 March 2019
4 references
30 January 2021
4 February 2021
28 April 2021
24 August 2022
5 references
30 January 2021
4 February 2021
28 April 2021
24 August 2022
4 references
30 January 2021
4 February 2021
28 April 2021
24 August 2022